These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 30570551)

  • 1. PRDM10-rearranged Soft Tissue Tumor: A Clinicopathologic Study of 9 Cases.
    Puls F; Pillay N; Fagman H; Palin-Masreliez A; Amary F; Hansson M; Kindblom LG; McCulloch TA; Meligonis G; Muc R; Rissler P; Sumathi VP; Tirabosco R; Hofvander J; Magnusson L; Nilsson J; Flanagan AM; Mertens F
    Am J Surg Pathol; 2019 Apr; 43(4):504-513. PubMed ID: 30570551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superficial CD34-positive fibroblastic tumor and PRDM10-rearranged soft tissue tumor are overlapping entities: a comprehensive study of 20 cases.
    Perret R; Michal M; Carr RA; Velasco V; Švajdler M; Karanian M; Meurgey A; Paindavoine S; Soubeyran I; Coindre JM; Boidot R; Charon-Barra C; Geneste D; Weingertner N; Pissaloux D; Tirode F; Baud J; Le Loarer F
    Histopathology; 2021 Nov; 79(5):810-825. PubMed ID: 34121219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superficial CD34-Positive Fibroblastic Tumor: A Clinicopathologic, Immunohistochemical, and Molecular Study of 59 Cases.
    Anderson WJ; Mertens F; Mariño-Enríquez A; Hornick JL; Fletcher CDM
    Am J Surg Pathol; 2022 Oct; 46(10):1329-1339. PubMed ID: 35713642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent PRDM10 Fusions in Superficial CD34-Positive Fibroblastic Tumors : A Clinicopathologic and Molecular Study of 10 Additional Cases of an Emerging Novel Entity.
    Zhao M; Yin X; He H; Fan Y; Ru G; Meng X
    Am J Clin Pathol; 2023 Apr; 159(4):367-378. PubMed ID: 36812381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Undifferentiated pleomorphic sarcomas with PRDM10 fusions have a distinct gene expression profile.
    Hofvander J; Puls F; Pillay N; Steele CD; Flanagan AM; Magnusson L; Nilsson J; Mertens F
    J Pathol; 2019 Dec; 249(4):425-434. PubMed ID: 31313299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overlapping morphological, immunohistochemical and genetic features of superficial CD34-positive fibroblastic tumor and PRDM10-rearranged soft tissue tumor.
    Puls F; Carter JM; Pillay N; McCulloch TA; Sumathi VP; Rissler P; Fagman H; Hansson M; Amary F; Tirabosco R; Magnusson L; Nilsson J; Flanagan AM; Folpe AL; Mertens F
    Mod Pathol; 2022 Jun; 35(6):767-776. PubMed ID: 34969957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical positive regulatory domain member 10 expression in soft tissue sarcomas.
    Mistik O; Sayar H
    Pol J Pathol; 2022; 73(3):223-232. PubMed ID: 36734437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent PRDM10 gene fusions in undifferentiated pleomorphic sarcoma.
    Hofvander J; Tayebwa J; Nilsson J; Magnusson L; Brosjö O; Larsson O; Vult von Steyern F; Mandahl N; Fletcher CD; Mertens F
    Clin Cancer Res; 2015 Feb; 21(4):864-9. PubMed ID: 25516889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superficial CD34 fibroblastic tumors and PRDM10-rearranged soft tissue neoplasm: An evolving diagnosis.
    Johnson C; Parsa L; Gibbs J; Sligh J
    J Cutan Pathol; 2024 Jan; 51(1):11-14. PubMed ID: 37150806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytogenetic analysis of 46 pleomorphic soft tissue sarcomas and correlation with morphologic and clinical features: a report of the CHAMP Study Group. Chromosomes and MorPhology.
    Mertens F; Fletcher CD; Dal Cin P; De Wever I; Mandahl N; Mitelman F; Rosai J; Rydholm A; Sciot R; Tallini G; Van den Berghe H; Vanni R; Willén H
    Genes Chromosomes Cancer; 1998 May; 22(1):16-25. PubMed ID: 9591630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superficial CD34 Positive Fibroblastic Tumour with Myxoid Stroma.
    Bruce-Brand C; Conradie W; Schneider JW
    Int J Surg Pathol; 2023 Aug; 31(5):751-754. PubMed ID: 36221951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathologic and molecular study of superficial CD34-positive fibroblastic tumours mimicking atypical fibrous histiocytoma (dermatofibroma).
    Wakefield CB; Mertens F; Fletcher CDM; Anderson WJ
    Histopathology; 2024 Dec; 85(6):939-949. PubMed ID: 39044682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myxoid pleomorphic liposarcoma-a clinicopathologic, immunohistochemical, molecular genetic and epigenetic study of 12 cases, suggesting a possible relationship with conventional pleomorphic liposarcoma.
    Creytens D; Folpe AL; Koelsche C; Mentzel T; Ferdinande L; van Gorp JM; Van der Linden M; Raman L; Menten B; Fritchie K; von Deimling A; Van Dorpe J; Flucke U
    Mod Pathol; 2021 Nov; 34(11):2043-2049. PubMed ID: 34168281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGFBR3 and MGEA5 rearrangements are much more common in "hybrid" hemosiderotic fibrolipomatous tumor-myxoinflammatory fibroblastic sarcomas than in classical myxoinflammatory fibroblastic sarcomas: a morphological and fluorescence in situ hybridization study.
    Zreik RT; Carter JM; Sukov WR; Ahrens WA; Fritchie KJ; Montgomery EA; Weiss SW; Folpe AL
    Hum Pathol; 2016 Jul; 53():14-24. PubMed ID: 26980036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Broadening the spectrum of NTRK rearranged mesenchymal tumors and usefulness of pan-TRK immunohistochemistry for identification of NTRK fusions.
    Brčić I; Godschachner TM; Bergovec M; Igrec J; Till H; Lackner H; Scheipl S; Kashofer K; Brodowicz T; Leithner A; Szkandera J; Liegl-Atzwanger B
    Mod Pathol; 2021 Feb; 34(2):396-407. PubMed ID: 32860002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of SynCAM3 and cyclin D1 immunohistochemistry in distinguishing superficial CD34-positive fibroblastic tumor from its histological mimics.
    Sugita S; Takenami T; Kido T; Aoyama T; Hosaka M; Segawa K; Sugawara T; Fujita H; Murahashi Y; Emori M; Tsuyuki A; Hasegawa T
    Med Mol Morphol; 2023 Mar; 56(1):69-77. PubMed ID: 36344703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGFBR3 and MGEA5 rearrangements in pleomorphic hyalinizing angiectatic tumors and the spectrum of related neoplasms.
    Carter JM; Sukov WR; Montgomery E; Goldblum JR; Billings SD; Fritchie KJ; Folpe AL
    Am J Surg Pathol; 2014 Sep; 38(9):1182-992. PubMed ID: 24705316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superficial ALK-rearranged myxoid spindle cell neoplasm: a cutaneous soft tissue tumor with distinctive morphology and immunophenotypic profile.
    Dermawan JK; Azzato EM; Goldblum JR; Rubin BP; Billings SD; Ko JS
    Mod Pathol; 2021 Sep; 34(9):1710-1718. PubMed ID: 34088997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel group of spindle cell tumors defined by S100 and CD34 co-expression shows recurrent fusions involving RAF1, BRAF, and NTRK1/2 genes.
    Suurmeijer AJH; Dickson BC; Swanson D; Zhang L; Sung YS; Cotzia P; Fletcher CDM; Antonescu CR
    Genes Chromosomes Cancer; 2018 Dec; 57(12):611-621. PubMed ID: 30276917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent BRAF Gene Rearrangements in Myxoinflammatory Fibroblastic Sarcomas, but Not Hemosiderotic Fibrolipomatous Tumors.
    Kao YC; Ranucci V; Zhang L; Sung YS; Athanasian EA; Swanson D; Dickson BC; Antonescu CR
    Am J Surg Pathol; 2017 Nov; 41(11):1456-1465. PubMed ID: 28692601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.